Trials / Terminated
TerminatedNCT04231409
Fast-Acting Subperception Study (FAST)
Study to Demonstrate the Value of Fast-Acting Subperception (FAST) Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain (COMBO Study)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Study to Demonstrate the Value of Fast-Acting Subperception (FAST) using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Boston Scientific Spectra WaveWriter SCS System | The Spectra WaveWriter Spinal Cord Stimulator (SCS) System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, Complex Regional Pain Syndrome (CRPS) Types I and II, intractable low back pain and leg pain. |
Timeline
- Start date
- 2019-11-26
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2020-01-18
- Last updated
- 2022-01-24
- Results posted
- 2022-01-24
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04231409. Inclusion in this directory is not an endorsement.